Cortical morphology variations during the menstrual cycle in individuals with and without premenstrual dysphoric disorder

被引:3
|
作者
Dubol, Manon [1 ]
Stiernman, Louise [2 ]
Sundstrom-Poromaa, Inger [3 ]
Bixo, Marie [2 ]
Comasco, Erika [1 ]
机构
[1] Uppsala Univ, Dept Womens & Childrens Hlth, Sci Life Lab, Uppsala, Sweden
[2] Umea Univ, Dept Clin Sci, Umea, Sweden
[3] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden
关键词
Premenstrual dysphoric disorder; Grey matter; Magnetic resonance imaging; Surface-based morphometry; Menstrual cycle; Mental health; CONTRACEPTIVE PILL USE; WOMEN; ABNORMALITIES; PREGNANCY; VOLUME;
D O I
10.1016/j.jad.2024.03.130
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Premenstrual dysphoric disorder (PMDD) is hypothesized to stem from maladaptive neural sensitivity to ovarian steroid hormone fluctuations. Recently, we found thinner cortices in individuals with PMDD, compared to healthy controls, during the symptomatic phase. Here, we aimed at investigating whether such differences illustrate state-like characteristics specific to the symptomatic phase, or trait-like features defining PMDD. Methods: Patients and controls were scanned using structural magnetic resonance imaging during the mid-follicular and late-luteal phase of the menstrual cycle. Group-by-phase interaction effects on cortical architecture metrics (cortical thickness, gyrification index, cortical complexity, and sulcal depth) were assessed using surface-based morphometry. Results: Independently of menstrual cycle phase, a main effect of diagnostic group on surface metrics was found, primarily illustrating thinner cortices (0.3 < Cohen's d > 1.1) and lower gyrification indices (0.4 < Cohen's d > 1.0) in patients compared to controls. Furthermore, menstrual cycle-specific effects were detected across all participants, depicting a decrease in cortical thickness (0.4 < Cohen's d > 1.7) and region-dependent changes in cortical folding metrics (0.4 < Cohen's d > 2.2) from the mid-follicular to the late luteal phase. Limitations: Small effects (d = 0.3) require a larger sample size to be accurately characterized. Conclusions: These findings provide initial evidence of trait-like cortical characteristics of the brain of individuals with premenstrual dysphoric disorder, together with indications of menstrual cycle-related variations in cortical architecture in patients and controls. Further investigations exploring whether these differences constitute stable vulnerability markers or develop over the years may help understand PMDD etiology.
引用
收藏
页码:470 / 477
页数:8
相关论文
共 50 条
  • [41] Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls—a pilot study
    Erika Timby
    Torbjörn Bäckström
    Sigrid Nyberg
    Hans Stenlund
    Anna-Carin N. Wihlbäck
    Marie Bixo
    Psychopharmacology, 2016, 233 : 2109 - 2117
  • [42] High prevalence of menstrual migraine comorbidity in patients with premenstrual dysphoric disorder: Retrospective survey
    Yamada, Kazuo
    CEPHALALGIA, 2016, 36 (03) : 294 - 295
  • [43] Progesterone and plasma metabolites in women with and in those without premenstrual dysphoric disorder
    Di Florio, Arianna
    Alexander, Danny
    Schmidt, Peter J.
    Rubinow, David R.
    DEPRESSION AND ANXIETY, 2018, 35 (12) : 1168 - 1177
  • [44] Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study
    Timby, Erika
    Backstrom, Torbjorn
    Nyberg, Sigrid
    Stenlund, Hans
    Wihlback, Anna-Carin N.
    Bixo, Marie
    PSYCHOPHARMACOLOGY, 2016, 233 (11) : 2109 - 2117
  • [45] Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle
    Kask, Kristiina
    Gulinello, Maria
    Baeckstroem, Torbjoern
    Geyer, Mark A.
    Sundstroem-Poromaa, Inger
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (09) : 2283 - 2290
  • [46] Patients with Premenstrual Dysphoric Disorder have Increased Startle Response Across both Cycle Phases and Lower Levels of Prepulse Inhibition During the Late Luteal Phase of the Menstrual Cycle
    Kristiina Kask
    Maria Gulinello
    Torbjörn Bäckström
    Mark A Geyer
    Inger Sundström-Poromaa
    Neuropsychopharmacology, 2008, 33 : 2283 - 2290
  • [47] Effect of tACS on prefrontal neural activity is menstrual phase dependent in patients with premenstrual dysphoric disorder
    Riddle, Justin
    Rubinow, David R.
    Frohlich, Flavio
    BRAIN STIMULATION, 2022, 15 (05) : 1088 - 1090
  • [48] Nociceptive Processing in Women With Premenstrual Dysphoric Disorder (PMDD) The Role of Menstrual Phase and Sex Hormones
    Bartley, Emily J.
    Palit, Shreela
    Kuhn, Bethany L.
    Kerr, Kara L.
    Terry, Ellen L.
    DelVentura, Jennifer L.
    Rhudy, Jamie L.
    CLINICAL JOURNAL OF PAIN, 2015, 31 (04): : 304 - 314
  • [49] Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle
    Hantsoo, Liisa
    Epperson, C. Neill
    NEUROBIOLOGY OF STRESS, 2020, 12
  • [50] Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli
    Gingnell, Malin
    Bannbers, Elin
    Wikstrom, Johan
    Fredrikson, Mats
    Sundstrom-Poromaa, Inger
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (11) : 1474 - 1483